Media Release 17 February 2014

GLOBAL HEALTH ANNOUNCES 31 DECEMBER 2013 HALF YEAR RESULTS

Global Health Limited (ASX: GLH) is pleased to report the Companys performance for the half year ended 31 December 2013.

Financial Highlights
38% increase in Net Profit After Tax (NPAT) of $697,509 compared to the Previous Corresponding Period to December 2012 EBITDA of $757,660 for the six months to 31 December 2013 (Dec 2012: $512,061) an increase of $245,599 (up 48%) Expected full year NPAT of between $1.5M and $1.7M for the 12 months to 30 June 2014

Operational Highlights
Total Operating Revenue increased by $456,411 (up 22%) to $2.546M for the six months to 31 December 2013 (Dec 2012: $2.089M) Licence and recurring subscription revenue increased by 18% to $1.9M (Dec 2012: $1.6M) representing 74% of total revenue (Dec 2012: 76.5%) Total Operating Expenses increased $210,812 (up 13%) to $1.788M (2012: $1.577M)

Key Highlights:

Half-Year Revenue
Total operating revenue increased by $456,411 (up 22%) to $2.546M for the six months to 31 December 2013 (Dec 2012: $2.089M). Licence and recurring subscription revenue increased by 18% to $1.9M (Dec 2012: $1.6M) representing 74% of total revenue (Dec 2012: 76.5%).
$3,000,000 $2,000,000 $1,000,000 $Dec-12 Licence Revenue Non-Licence Revenue $1,599,812 $489,507 Dec-13 $1,889,076 $656,654

Half-Year Expenses
$2,000,000

Total operating expenses increased $210,812 (up 13%) to $1.788M (2012: $1.577M). The increase was primarily through increased expenditure on Sales and Marketing.

$1,500,000 $1,000,000 $500,000 $Total Expenses Dec-12 $1,577,258 Dec-13 $1,788,070

The Company achieved Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) of $757,660 for the six months to 31 December 2013 (Dec 2012: $512,061) an increase of $245,599 (up 48%). EBITDA Margins increased by 5% to 30% of total revenue (2012: 25%) a percentage improvement of 20%. The EBITDA indicators continue a positive trend over the last 5 half-year periods from December 2011 through to December 2013 reflecting the largely fixed cost profile of the Companys operations.

6-Monthly EBITDA
$1,000,000 $800,000 $600,000 $400,000 $200,000 $0 ($200,000) ($400,000) ($600,000) EBITDA EBITDA Margin -10% -30% -50% 50% 30% 10%

6-Monthly NPAT
The resultant Net Profit After Tax (NPAT) for the 6 months to 31 December 2013 was $697,509 (Dec 2012: $506,435) an increase of $191,074 (up 38%). NPAT margins increased by 3% to 27% of total revenue (2012: 24%) a percentage improvement of 12.5%.
$800,000 $600,000 $400,000 $200,000 $0 ($200,000) ($400,000) ($600,000) NPAT NPAT Margin -30% -50% 10% -10% 50% 30%

Forward Outlook
The Company has experienced an increase in sales activity over the reporting period and a healthy project fulfilment backlog. These are encouraging trends that have continued into the current period. Global Health is expecting a full year net profit after tax (NPAT) of between $1.5M and $1.7M for the 12 months to 30 June 2014 subject to current market conditions being maintained over the current period. In commenting on the half year results, Mathew Cherian, CEO of Global Health Limited said: I am delighted that our team has delivered a strong half year result with a 38% increase in NPAT and an EBITDA increase of 48% compared to the previous corresponding period. We look forward to continuing to build shareholder value in the years ahead.

ABOUT GLOBAL HEALTH LIMITED Global Health is a leading provider of e-health solutions to the Australian healthcare industry, supporting healthcare delivery in hospitals and community settings. Global Health supports the business, clinical and operational needs of healthcare providers committed to the effective management of chronic diseases and health promotion programs. Internet connectivity is embedded in Global Health applications to promote secure information sharing, financial transaction and the use of technology in ways that transform healthcare delivery. Global Health is listed on the Australian Securities Exchange with its head office based in Melbourne. For more information please visit: www.global-health.com

For further information please contact:

Mathew Cherian, CEO and Managing Director Global Health Limited T: (03) 9675 0688 Rod North, Managing Director Bourse Communications Pty Ltd T: (03) 9510 8309 M: 0408 670 706 E: rod@boursecommunications.com.au